Abstract
Research Article | Open Access
Volume 2024 - 1 | Article ID 217 | http://dx.doi.org/10.62057/ESJ.2024.V1.I3
FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF PERAMPANEL IMMEDIATE RELEASE TABLETS
Received 2024-02-29 |
Revised 2024-03-04 |
Accepted 2024-03-05 |
Published 2024-03-10 |
M. Vennela1* Dr. S. Dinesh Mohan2
1. Vishnu
Institute of Pharmaceutical Education and Research, Department of
Pharmaceutics, Vishnupur, Narsapur, Medak, India. 2. Vishnu Institute of
Pharmaceutical Education and Research, Department of Pharmaceutics, Associate
Professor Vishnupur, Narsapur, Medak, India.
Corresponding Author: M. Vennela, Vishnu
Institute of Pharmaceutical Education and Research, Department of
Pharmaceutics, Vishnupur, Narsapur, Medak, India, Email: vennela.m.200492a@gmail.com
Citation: M.
Vennela, Dr. S. Dinesh Mohan (2024). Formulation Development And
Invitro Evaluation Of Perampanel Immediate Release Tablets Formulation
Development And Invitro Evaluation Of Perampanel Immediate Release Tablets. Eco
Science Journal. 2024 1(3)
Copyrights © 2024, M.
Vennela.
This article is licensed under the Creative Commons
Attribution-NonCommercial-4.0-International-License-(CCBY-NC)
Abstract
The aim of the present study is to
develop and evaluate the immediate release tablet of Perampanel by direct
compression method. The superdisintegrant crospovidone (CP), croscarmellose
sodium (CCS) and sodium starch glycolate (SSG) were used for immediate release
of drug from tablet. The prepared tablets were evaluated for all
pre-compression parameters and post-compression parameters. The drug excipients
interaction was investigated by FTIR. All formulation showed compliances with
Pharmacopoeial standards. The study reveals that formulations prepared by
direct compression F3 exhibit highest dissolution using crospovidone showed
faster drug release 99.13 % over the period of 45min.
Keywords: Immediate Release Tablets, Perampanel, Crospovidone (CP), Croscarmellose sodium (CCS), Sodium starch glycolate (SSG).